User profiles for Leonard Buckbinder

Leonard Buckbinder

Vice President, Biology; Scorpion Therapeutics
Verified email at scorpiontx.com
Cited by 5341

Induction of the growth inhibitor IGF-binding protein 3 by p53

L Buckbinder, R Talbott, S Velasco-Miguel, I Takenaka… - Nature, 1995 - nature.com
TRANSCRIPTIONAL activation of target genes represents an important component of the
tumour-suppressor function of p53 and provides a functional link between p53 and various …

NF-κB RelA phosphorylation regulates RelA acetylation

…, Y Mu, H Nakano, JM Duerr, L Buckbinder… - … and cellular biology, 2005 - Taylor & Francis
The nuclear functions of NF-κB p50/RelA heterodimers are regulated in part by posttranslational
modifications of its RelA subunit, including phosphorylation and acetylation. Acetylation …

[HTML][HTML] Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure

…, J Brandimarto, MR Brown, L Buckbinder… - Nature …, 2020 - nature.com
Heart failure (HF) is a leading cause of morbidity and mortality worldwide. A small proportion
of HF cases are attributable to monogenic cardiomyopathies and existing genome-wide …

PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes

S Velasco-Miguel, L Buckbinder, P Jean, L Gelbert… - Oncogene, 1999 - nature.com
Exposure of mammalian cells to hypoxia, radiation and certain chemotherapeutic agents
promotes cell cycle arrest and/or apoptosis. Activation of p53 responsive genes is believed to …

Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis

L Buckbinder, DT Crawford, H Qi… - Proceedings of the …, 2007 - National Acad Sciences
Bone is accrued and maintained primarily through the coupled actions of bone-forming
osteoblasts and bone-resorbing osteoclasts. Cumulative in vitro studies indicated that proline-…

Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning

…, C Hage, A Sharma, MJ Brosnan, L Buckbinder… - Heart, 2020 - heart.bmj.com
Objective Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome.
We aimed to derive HFpEF phenotype-based groups ('phenogroups') based on clinical …

[HTML][HTML] Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design

…, DP Walker, AD Brosius, L Buckbinder - Journal of biological …, 2009 - ASBMB
Proline-rich tyrosine kinase 2 (PYK2) is a cytoplasmic, non-receptor tyrosine kinase implicated
in multiple signaling pathways. It is a negative regulator of osteogenesis and considered …

Myeloperoxidase inhibition improves ventricular function and remodeling after experimental myocardial infarction

…, FK Swirski, M Nahrendorf, L Buckbinder… - JACC: Basic to …, 2016 - jacc.org
PF-1355 is an oral myeloperoxidase (MPO) inhibitor that successfully decreased elevated
MPO activity in mouse myocardial infarction models. Short duration PF-1355 treatment for 7 …

[HTML][HTML] Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis

…, MP Cooper, TP Fitzgibbons, L Buckbinder… - Nature …, 2015 - nature.com
Signalling pathways that control endothelial cell (EC) permeability, leukocyte adhesion and
inflammation are pivotal for atherosclerosis initiation and progression. Here we demonstrate …

Understanding the impact of the P-loop conformation on kinase selectivity

…, J Wang, SK Bhattacharya, L Buckbinder - Journal of chemical …, 2011 - ACS Publications
This work addresses the link between selectivity and an unusual, folded conformation for
the P-loop observed initially for MAP4K4 and subsequently for other kinases. Statistical and …